| Detected | Trial | Change |
|---|---|---|
| 2026-06-03 | NCT04128748 Liposomal Cytarabine and Daunorubicin (CPX-351) and Quizartinib for the Treatment of… |
overall status: "Recruiting" → "Active Not Recruiting" |
| 2026-05-28 | NCT06983665 Human Bioequivalence Study of Liposomal Amphotericin B for Injection |
Trial completed |
| 2026-05-28 | NCT06983665 Human Bioequivalence Study of Liposomal Amphotericin B for Injection |
Enrollment increased: 42 -> 58 participants |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-06-08 | NCT07632274 A Study to Evaluate Ibuprofen (IBU) 62.5 mg and Acetaminophen (APAP) 125 mg/5 ml in an… | Phase 1 | Not Yet Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT06578247 | Quizartinib or Placebo Plus Chemotherapy in Newly Diagnosed Patients With FLT3-ITD… | Leukemia | Recruiting |
| NCT07478991 | Azacytidine, Venetoclax Plus Minus Quizartinib for First Line Older/Unfit AML Patients… | Acute Myeloid Leukemia, Adult | Not Yet Recruiting |
| Phase 1/2 | |||
| NCT03661307 | Quizartinib, Decitabine, and Venetoclax in Treating Participants With Untreated or… | Acute Myeloid Leukemia | Recruiting |
| NCT03793478 | Safety and Efficacy of Quizartinib in Children and Young Adults With Acute Myeloid… | Acute Myeloid Leukemia | Active, Not Recruiting |
| NCT04493138 | Azacitidine and Quizartinib for the Treatment of Myelodysplastic Syndrome or… | Chronic Myelomonocytic Leukemia | Active, Not Recruiting |
| NCT04128748 | Liposomal Cytarabine and Daunorubicin (CPX-351) and Quizartinib for the Treatment of… | Acute Myeloid Leukemia | Active, Not Recruiting |
| Phase 1 | |||
| NCT06769490 | Dose Escalation and Expansion of Ziftomenib in Combination With Quizartinib in Acute… | Acute Myeloid Leukemia | Recruiting |
| NCT05735184 | A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With… | Acute Myeloid Leukemia | Recruiting |
| NCT06740799 | Assessment of Quizartinib Pharmacokinetic in Subjects With Severe Hepatic Impairment | Hepatic Impairment | Recruiting |
| NCT07632274 | A Study to Evaluate Ibuprofen (IBU) 62.5 mg and Acetaminophen (APAP) 125 mg/5 ml in an… | Pain | Not Yet Recruiting |